The William O. Russell Annual Conference: Nuts and Bolts in Surgical Pathology

---

LIVEDiagnostic Pitfalls in PathologyUpdates in Surgical PathologyPractical Surgical Pathology UpdatesDiagnostic SkillsMolecular + Morphology IntegrationTumor DiagnosesLiquid Biopsy & Future Diagnostics

Friday, December 4, 2026, 7:00 AM - Saturday, December 5, 2026, 3:00 PM, MD Anderson - Onstead Auditorium, Houston, TX


AMA PRA Category 1 Credits™ (14.00 hours), ABPath MOC Part II (14.00 hours), Non-Physician Attendance (14.00 hours)

This activity in Diagnostic Surgical Pathology provides an in-depth exploration of current and emerging concepts in tumor classification, challenging diagnostic scenarios, and the molecular advances shaping modern pathology. Designed to elevate diagnostic accuracy and confidence, the program equips participants with practical strategies to navigate complex cases, recognize diagnostic pitfalls, and integrate new testing modalities into routine practice. Through expert led lectures, interactive discussions, and real-world case studies, attendees gain actionable insights and updated tools that directly support high quality, precise patient care in surgical pathology.

1. Recognize significant updates and emerging trends in diagnostic and surgical pathology that influence current clinical practice.
2. Integrate updated diagnostic criteria and biomarker developments to improve accuracy in evaluating neoplastic and non-neoplastic lesions.
3. Incorporate molecular and immunohistochemical testing more effectively to strengthen diagnostic interpretation and support high-quality patient care.

The William O. Russell Annual Conference: Nuts and Bolts in Surgical Pathology conference will be held on December 4-5, 2026, at UT MD Anderson's Mitchell Building, Onstead Auditorium, located at 6767 Bertner Ave., Houston, TX 77030.

Day 1: Begins on Friday, December 4, 2026, with Welcome and Remarks at 8:00 AM, followed by a Welcome Reception at 5:00 PM, inclusive of all speakers, learners, and industry sponsors.

Day 2: Reconvenes on Saturday, December 5, 2026, at 8:30 AM and will adjourn at 3:00 PM with Farewell and Adjournment.

This two-day activity will explore the latest advancements in tumor and surgical pathology, including evolving classification systems, diagnostic challenges, and the integration of molecular and ancillary testing. Through expert-led discussions and real-world case-based presentations, the course aims to enhance diagnostic accuracy and provide practical tools that can be applied in daily practice to improve patient care. This activity also offers an opportunity to earn Maintenance of Certification (MOC) Part II credit for the American Board of Pathology.

Registration Fees:

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to:

Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407
Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy The registration fee, minus a $50.00 administration-handling fee, is refundable if a written request is received on or before Wednesday, November 4, 2026.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE, will refund the full registration fee. CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Special Assistance
Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology
This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.00 Lifelong Learning credits. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABPath MOC credit.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.